Philip S. Bauer

Philip S. Bauer

Auto-generated profile, based on publicly available information

Philip S. Bauer

Washington University School of Medicine, Department of Surgery, St. Louis, MO

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MWMartin R. Weiser
Martin R. Weiser
MHMeier Hsu
Meier Hsu
PBPhilip S. Bauer
Philip S. Bauer
WCWilliam C. Chapman
William C. Chapman
IGIván A. González
Iván A. González
MGMithat Gonen
Mithat Gonen
PURPOSE: Clinical calculators and nomograms have been endorsed by the American Joint Committee on Cancer (AJCC), as they provide the most individualized and accurate estimate of patient outcome. Using molecular and clinicopathologic variables, a third-generation clinical calculator was built to predict recurrence following resection of stage I-III colon cancer. METHODS: Prospectively collected data from 1,095 patients who underwent colectomy between 2007 and 2014 at Memorial Sloan Kettering Cancer Center were used to develop a clinical calculator. Discrimination was measured with concordance index, and variability in individual predictions was assessed with calibration curves. The clinical calculator was externally validated with a patient cohort from Washington University's Siteman Cancer Center in St Louis. RESULTS: The clinical calculator incorporated six variables: microsatellite genomic phenotype; AJCC T category; number of tumor-involved lymph nodes; presence of high-risk pathologic features such as venous, lymphatic, or perineural invasion; presence of tumor-infiltrating lymphocytes; and use of adjuvant chemotherapy. The concordance index was 0.792 (95% CI, 0.749 to 0.837) for the clinical calculator, compared with 0.708 (95% CI, 0.671 to 0.745) and 0.757 (0.715 to 0.799) for the staging schemes of the AJCC manual's 5th and 8th editions, respectively. External validation confirmed robust performance, with a concordance index of 0.738 (95% CI, 0.703 to 0.811) and calibration plots of predicted probability and observed events approaching a 45° diagonal. CONCLUSION: This third-generation clinical calculator for predicting cancer recurrence following curative colectomy successfully incorporates microsatellite genomic phenotype and the presence of tumor-infiltrating lymphocytes, resulting in improved discrimination and predictive accuracy. This exemplifies an evolution of a clinical calculator to maintain relevance by incorporating emerging variables as they become validated and accepted in the oncologic community.

1 October 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
JAJonathan Abelson
Jonathan Abelson
JBJohn Barron
John Barron
PBPhilip S. Bauer
Philip S. Bauer
WCWilliam C. Chapman
William C. Chapman
CSChristine Schad
Christine Schad
MSMatthew Silviera
Matthew Silviera

1 October 2020 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PBPhilip S. Bauer
Philip S. Bauer
EOEbunoluwa E. Otegbeye
Ebunoluwa E. Otegbeye
MSMatthew L. Silviera
Matthew L. Silviera
SHSteven R. Hunt
Steven R. Hunt
MMMatthew G. Mutch
Matthew G. Mutch
PWPaul E. Wise
Paul E. Wise

27 June 2026 in Seminars in Colon and Rectal Surgery
Verified
Journal Article
Open access
NWNikita Wadhwani
Nikita Wadhwani
PBPhilip S. Bauer
Philip S. Bauer
MKMatthew F. Kalady
Matthew F. Kalady

1 October 2019 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
ADAneel Damle
Aneel Damle
PBPhilip S. Bauer
Philip S. Bauer
VPVictoria Peck
Victoria Peck
CAChady Atallah
Chady Atallah
DRDavid Rosen
David Rosen
MSMatthew Silviera
Matthew Silviera

1 November 2021 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MMM. Moskalenko
M. Moskalenko
HKHyoungil Kim
Hyoungil Kim
RCR.I. Chin
R.I. Chin
ARA. Roy
A. Roy
SBS.N. Badiyan
S.N. Badiyan
JOJ.R. Olsen
J.R. Olsen